GREENVILLE, SC—Womble Bond Dickinson attorneys Stephanie Few , Keith Munson and Catherine Wrenn , along with team members Heather Hatcher , Martika Harper , and Rudy Gaines attended the SCBIO conference held at the Hyatt Regency Greenville on October 29-31. The conference had a record attendance whose participants came from 11 countries, 32 states and all the counties of South Carolina. The event saluted three life sciences leaders for profound positive impact and exceptional contributions to the advancement of South Carolina’s sciences industry. Those saluted included retired University of South Carolina President Dr. Harris Pastides, recently retired EVP and Chief Academic Officer of Prisma Health and Founding Dean of the USC School of Medicine Dr. Jerry Youkey and the AVX Corporation of Fountain Inn.

Stephanie Few is on the Board of SCBIO and introduced South Carolina Lt. Governor Pamela Evette on Wednesday October 30th.

SCBIO is the Carolinas’ statewide, not-for-profit, public/private life sciences industry association and economic development organization formed to actively promote, build, support, expand, and convene South Carolina's life sciences industry.

Womble Bond Dickinson is a Premier Sponsor of SCBIO.

Stephanie Few has played a role in many of South Carolina’s largest economic development deals of the past 20 years. She works closely with companies seeking to expand or relocate operations to the Carolinas and the Southeastern United States. Her efforts on behalf of clients have led to the creation of thousands of new jobs and billions of dollars in new investments. When the New York Times profiled Charleston’s economic boom in 2017, Few was one of the local leaders the Times turned to for insight.

Keith Munson is a trial lawyer with more than 30 years of experience representing major corporations and governmental entities in complex litigation in the areas of product liability defense, mass tort defense, class action litigation, director and officer liability, and civil/securities fraud.

Catherine Wrenn litigates cases for businesses and health care providers, including physicians, hospitals, skilling nursing facilities, and assisted living facilities. Her practice includes advising clients on regulatory compliance and handling matters that involve Medicare fraud, wrongful death, personal injury, negligence, breach of contract, and breach of warranty.

Heather Hatcher has extensive experience in Regulatory Affairs and as a basic and clinical research scientist. She effectively guides clients through the complex regulatory landscape governed by the US Food and Drug Administration (FDA) toward market authorization. In addition to advising clients on early regulatory strategy and product development issues, Heather prepares regulatory submissions to the FDA for drugs, biologics, and medical devices. Heather also helps clients prepare responses to the FDA and provides regulatory advice on best practices for Phase I/Phase II clinical trials, standard operating procedures and protocols for Good Manufacturing Practices (GMP), and quality control testing for stem cell therapy and biomaterials. She has experience researching predicate devices for 510(k) submissions, and preparing requests for Humanitarian Use Device (HUD) and Humanitarian Device Exemption (HDE).

Martika Harper is an integral part of Womble Bond Dickinson’s in-house Regulatory Affairs team. She has experience preparing regulatory submissions to FDA for drugs, biologics, and medical devices including: Investigational New Drug applications, Investigational Device Exemption applications and meeting requests.